Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma
Open Access
- 7 October 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 99 (9), 1468-1475
- https://doi.org/10.1038/sj.bjc.6604719
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation ResistanceClinical Cancer Research, 2006
- Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancerLung Cancer, 2006
- Expression of Carbonic Anhydrase IX (CA IX), a Hypoxia-Related Protein, Rather Than Vascular-Endothelial Growth Factor (VEGF), a Pro-Angiogenic Factor, Correlates With an Extremely Poor Prognosis in Esophageal and Gastric AdenocarcinomasAnnals of Surgery, 2006
- Review ArticleJournal of Enzyme Inhibition and Medicinal Chemistry, 2004
- Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.2003
- Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomasRadiotherapy and Oncology, 2003
- Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast CarcinomaJournal of Clinical Oncology, 2001
- Hypoxia-inducible expression of tumor-associated carbonic anhydrases.2000
- MN antigen expression in normal, preneoplastic, and neoplastic esophagus: A clinicopathological study of a new cancer-associated biomarkerHuman Pathology, 1997
- Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.1996